SCHEMBL4379672

SCHEMBL4379672

CC(C)COC(=O)N[C@@H](Cc1c(F)cccc1F)CN1C(=O)c2ccccc2C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.43
MEN1 O00255 1/20 0.43
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 2/20 0.41
PLA2G1B P04054 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
TSHR P16473 2/20 0.39
LMNA P02545 1/20 0.39
ALOX15 P16050 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP3A4 P08684 4/20 0.39
CYP2C19 P33261 4/20 0.39
CYP2D6 P10635 3/20 0.39
CYP2C9 P11712 3/20 0.39
TRPA1 O75762 1/20 0.38
POLB P06746 1/20 0.38
CYP1A2 P05177 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4336440 0.85 CYP2D6 (0.41) KMT2AMEN1RAB9AKDM4EALDH1A1
SCHEMBL12679227 0.84 SCN9A (0.44) KMT2AMEN1RAB9AKDM4EALDH1A1
SCHEMBL3506831 0.82 POLB (0.44) KMT2AMEN1RAB9AKDM4EALDH1A1
SCHEMBL4381682 0.81 KMT2A (0.43) KMT2AMEN1RAB9AKDM4EALDH1A1
SCHEMBL4583413 0.80 KMT2A (0.50) KMT2AMEN1RAB9AALDH1A1CYP3A4
SCHEMBL5551458 0.79 PLA2G1B (0.47) KMT2AMEN1RAB9AKDM4EALDH1A1
SCHEMBL4374776 0.78 CYP3A4 (0.48) KMT2ARAB9AKDM4EALDH1A1PLA2G1B
SCHEMBL4728727 0.69 ATM (0.50) POLB
SCHEMBL13260263 0.69 ATM (0.45) RAB9AKDM4EALDH1A1HPGD
SCHEMBL683030 0.69 CTSS (0.52) ALDH1A1HPGDHTTTSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2117523-A1 INHIBITORS OF AKT ACTIVITY SmithKline Beecham Corporation (US) 2009-11-18 EP disclosed
WO-2008098104-A1 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2008-08-14 WO disclosed